GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Er Therapeutics PNGM · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

About Er Therapeutics

Its shares trade under the ticker PNGM. It has been listed since 10 August 2007.

Pengram Corp. engages in the acquisition, exploration and development of zinc, lead, vanadium, and galena. The company is headquartered in Bellingham, Washington. The company went IPO on 2007-08-10. The firm has not realized any revenues from its planned operations. The firm is engaged in acquiring exploration and development of natural resource properties. The firm has not commenced business operations. The firm has interests in Clisbako claims and Eureka claims. The firm has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The firm also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
10 Aug 2007

Leadership

Pay as last reported

  • Richard DonaldsonPresident, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director, since 2008$12,000
  • Howard MetzlerDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.